Latest Kuano News & Updates

See the latest news and media coverage for Kuano. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Kuano

Quantum simulation and AI drug discovery platform

kuano.ai
Headquarters
London, United Kingdom
Company type
Private company
Number of employees
2–15

Last updated

Latest news about Kuano

In short: Kuano advanced its quantum-enabled drug discovery platform, launched new technology, and secured $1.8M in seed funding to target complex enzymes.

Company announcements

Kuano

Kuano introduces Quantum Lens technology

It unlocks undruggable targets using quantum chemistry and active learning. Successfully identified 3 novel chemotypes for DNMT1 from 40 compounds.

Kuano

Kuano partners with Onco-Innovations Ltd

The collaboration deploys Kuano's quantum-enabled platform to tackle challenging targets like PNKP. Kuano seeks additional partners for drug development bottlenecks.

Kuano

Kuano unveils new Quantum Lens service

It combines AI with physics-based models to accelerate discovery, tackle difficult targets, and de-risk pipelines via an integrated design engine and expert support.

Unlock all announcements with a

Media coverage

Medium

Why We Invested In Kuano. By Ruth Coleman and Robert Hornby… | by WhyWeInvested | Medium

By Ruth Coleman and Robert Hornby, investors at Mercia Ventures.

Unlock all articles with a

Never miss news about Kuano

Track Kuano and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.